Zogenix is committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases.
Innovation in Rare Disease
Zogenix is a growing U.S.-based pharmaceutical company passionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families.
To learn more about the company’s current development projects, click here.
At Zogenix, we strive to make a difference in the lives of patients, their families, and our employees by operating ethically with the following values:
Zogenix is pleased to provide opportunities for unrestricted grants in support of independent medical education activities for health care professionals as well as organizations who request funds for a specific project, meeting, or other organized initiative that is in alignment with the company’s areas of interest.
We continually review opportunities identified by our business development team and strategic investment partners. To discuss potential business development opportunities, please contact: firstname.lastname@example.org
Zogenix is based in the United States and has additional offices in Europe and Japan.
To learn more about our locations and how to contact us, click here.